These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26166425)

  • 1. A longitudinal cohort study of the relationship between Thimerosal-containing hepatitis B vaccination and specific delays in development in the United States: Assessment of attributable risk and lifetime care costs.
    Geier DA; Kern JK; Hooker BS; King PG; Sykes LK; Geier MR
    J Epidemiol Glob Health; 2016 Jun; 6(2):105-18. PubMed ID: 26166425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk for an atypical autism diagnosis following Thimerosal-containing vaccine exposure in the United States: A prospective longitudinal case-control study in the Vaccine Safety Datalink.
    Geier DA; Kern JK; Geier MR
    J Trace Elem Med Biol; 2017 Jul; 42():18-24. PubMed ID: 28595786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional study of the relationship between infant Thimerosal-containing hepatitis B vaccine exposure and attention-deficit/hyperactivity disorder.
    Geier DA; Kern JK; Homme KG; Geier MR
    J Trace Elem Med Biol; 2018 Mar; 46():1-9. PubMed ID: 29413097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services.
    Geier DA; Kern JK; Homme KG; Geier MR
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29329213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.
    Geier DA; Hooker BS; Kern JK; King PG; Sykes LK; Geier MR
    Int J Environ Res Public Health; 2014 Sep; 11(9):9156-70. PubMed ID: 25198681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thimerosal exposure and disturbance of emotions specific to childhood and adolescence: A case-control study in the Vaccine Safety Datalink (VSD) database.
    Geier DA; Kern JK; Homme KG; Geier MR
    Brain Inj; 2017; 31(2):272-278. PubMed ID: 28102704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thimerosal-containing hepatitis B vaccination and the risk for diagnosed specific delays in development in the United States: a case-control study in the vaccine safety datalink.
    Geier DA; Kern JK; Hooker BS; King PG; Sykes LK; Geier MR
    N Am J Med Sci; 2014 Oct; 6(10):519-31. PubMed ID: 25489565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink.
    Geier DA; Kern JK; Homme KG; Sykes LK; Geier MR
    N Am J Med Sci; 2016 Jul; 8(7):297-306. PubMed ID: 27583238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink.
    Geier DA; Kern JK; Geier MR
    Toxics; 2018 Nov; 6(4):. PubMed ID: 30445743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States.
    Geier DA; Kern JK; King PG; Sykes LK; Geier MR
    Biol Trace Elem Res; 2015 Feb; 163(1-2):28-38. PubMed ID: 25382662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
    Young HA; Geier DA; Geier MR
    J Neurol Sci; 2008 Aug; 271(1-2):110-8. PubMed ID: 18482737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
    Dórea JG; Marques RC; Brandão KG
    Am J Perinatol; 2009 Aug; 26(7):523-7. PubMed ID: 19283656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-phase study evaluating the relationship between Thimerosal-containing vaccine administration and the risk for an autism spectrum disorder diagnosis in the United States.
    Geier DA; Hooker BS; Kern JK; King PG; Sykes LK; Geier MR
    Transl Neurodegener; 2013 Dec; 2(1):25. PubMed ID: 24354891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.
    Biroscak BJ; Fiore AE; Fasano N; Fineis P; Collins MP; Stoltman G
    Pediatrics; 2003 Jun; 111(6 Pt 1):e645-9. PubMed ID: 12777580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early exposure to thimerosal-containing vaccines and children's cognitive development. A 9-year prospective birth cohort study in Poland.
    Mrozek-Budzyn D; Majewska R; Kiełtyka A
    Eur J Pediatr; 2015 Mar; 174(3):383-91. PubMed ID: 25185528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.
    Brayden RM; Pearson KA; Jones JS; Renfrew BL; Berman S
    J Pediatr; 2001 May; 138(5):752-5. PubMed ID: 11343056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.
    Thomas AR; Fiore AE; Corwith HL; Cieslak PR; Margolis HS
    Pediatr Infect Dis J; 2004 Apr; 23(4):313-8. PubMed ID: 15071284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage.
    Luman ET; Fiore AE; Strine TW; Barker LE
    JAMA; 2004 May; 291(19):2351-8. PubMed ID: 15150207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.